← 홈

전체 프로그램

ADC 1036 · Antibody 5161 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 20일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,007개
AntibodystaleEli LillyPhase 2

Cetuximab, Irinotecan, Capecitabine (Cetuximab, Irinotecan, Capecitabine)

Rectal Neoplasms; Neoadjuvant Treatment · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab,Paclitaxel, Carboplatin (Cetuximab,Paclitaxel, Carboplatin)

Esophageal Cancer; Gastric Cancer · Esophageal Cancer

#EsophagealCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab,Paclitaxel,Cisplatin (Cetuximab,Paclitaxel,Cisplatin)

Oral Cancer · Oral Cancer

#OralCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab-IRDye800CW (Cetuximab-IRDye800CW)

Head and Neck Squamous Cell Carcinoma; Margin Assessment · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab-Zr. 89 (Cetuximab-Zr. 89)

Stage IV Cancer · Stage IV Cancer

#StageIVCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab/Gefitinib combination and/or monotherapy (Cetuximab/Gefitinib combination and/or monotherapy)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab/Gemcitabine (Cetuximab/Gemcitabine)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 3%임상시험 1상태 ACTIVE
ADCBiologicstaleSun Yat-Sen Memorial Hospital o…Phase 1

Chemotherapeutic drug, ADC or PARP inhibitor (Chemotherapeutic drug, ADC or PARP inhibitor)

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleFirst Affiliated Hospital of Zh…Phase 2

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

HIV (Human Immunodeficiency Virus) · HIV (Human Immunodeficiency Virus)

#HIVHumanImmunodeficiencyVirus#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleGuangzhou 8th People's HospitalPhase 1

Chidamide with CAR-T or TCR-T cell therapy (Chidamide with CAR-T or TCR-T cell therapy)

HIV/AIDS · HIV/AIDS

#HIVAIDS#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleJohn ListerPhase 2

Chimeric Antigen Receptor (CAR, Chimeric Antigen Receptor, Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous))

B-Cell Lymphoma; B Acute Lymphoblastic Leukemia · B-Cell Lymphoma

#B-CellLymphoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleJennifer Crombie, MDPhase 2

Chimeric Antigen Receptor (CAR, Chimeric Antigen Receptor, Chimeric Antigen Receptor (CAR) Therapy Infusion)

Primary Mediastinal Large B-cell Lymphoma (PMBCL); Primary Mediastinal Large B Cell Lymphoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 67%임상시험 1상태 RECRUITING
CGTBiologicstaleSouthwest Hospital, ChinaPhase 2

Chimeric Antigen Receptor Modified T cells Targeting CD19 (Chimeric Antigen Receptor Modified T cells Targeting CD19)

Leukemia; Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleO&D BioTech Group CO., LimitedPhase 1

Chimeric antigen receptor T cell O&D-001 injection targeting BCMA and GPRC5D (Chimeric antigen receptor T cell O&D-001 injection targeting BCMA and GPRC5D)

Relapsed or Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleThe Affiliated Hospital of Qing…Preclinical

Chimeric antigen receptor T cell preparation targeting GCC (Chimeric antigen receptor T cell preparation targeting GCC)

Colon Cancer · Colon Cancer

#ColonCancer#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleNelson HamerschlakPhase 1

Chimeric antigen receptor T cells to be implemented in a "3 + 3" design on day 0 (Chimeric antigen receptor T cells to be implemented in a "3 + 3" design on day 0)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

Chimeric antigen receptor modified γδ T cells (Chimeric antigen receptor modified γδ T cells)

CAR; Malignant Tumors · CAR

#CAR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleNational University Hospital, S…Phase 2

trastuzumab (Herceptin, Chimeric receptor T-cells + Trastuzumab)

HER2+ Advanced Breast Cancer; Other Solid Tumors · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

112 / 201 페이지

← 이전다음 →